retatrutide clinical development peptide Retatrutide for Weight Loss: TRIUMPH-1

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults with Overweight or Obesity without Diabetes: The STEP 8 Randomized Clinical Trial

How to use Tribedoce Injections

Available in 600 mg and 1500 mg vial sizes

The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan